Analysts see rating downgrade hitting everyone's pocket

Moody's offices in Vilnius  credit: Shutterstock/Andrius Zemaitis
Moody's offices in Vilnius credit: Shutterstock/Andrius Zemaitis

Chen Herzog of CEO: The downgrade will mean higher taxes, higher prices, erosion of wages, and also harm to savings and pensions

On Friday, International credit rating agency Moody’s announced a double downgrade of Israel’s sovereign rating to Baa1, and appended a negative outlook, meaning that the rating is liable to be downgraded further within the next eighteen months to two years.

Apart from the change itself, which puts Israel on a par with much less successful economies, the downgrade has significant implications.

The Israeli capital market may have appeared to ignore previous rating downgrades, and equities indices even reached new peaks on Thursday, but it doesn’t really shake them off so easily. The downgrade announcement will find expression in a host of elements that in the end affect the lives of all of us. Israel’s national debt becomes more expensive, taxes will have to rise to finance that, inflation will probably fall more slowly, and the bond market is also likely to respond, harming everyone’s pension savings.

The immediate significance of the downgrade is that the ability of the Israeli government to repay its debts is considered lower. That means that new debt will be more expensive to raise, i.e., lenders will demand higher interest rates to compensate for the higher risk. In that respect, however, the effect of the downgrade announcement will be limited, since Israel’s risk premium, as expressed in the spread between interest rates on Israel government bond and US ten-year Treasury bonds already represents a rating more like BBB.

Chen Herzog, chief economist at BDO Consulting Israel, explains that the rating downgrade creates a domino effect. "Interest rates on government debt rise because of the low rating, further swelling the fiscal deficit. Higher government spending on servicing its debt makes it necessary to raise taxes and cut other spending, worsening the economic slowdown."

The burden on the public will grow

In addition, because of the harm to the economy, the Israeli public’s savings are also likely to be harmed. The lower rating is liable to affect adversely the performance of pension funds and advanced training funds. Herzog stresses that the consequences of the rating downgrade will reach the public’s pocket because of "higher taxes, higher prices, erosion of wages, and also harm to savings and pensions because of the effect of an economic slowdown and higher interest rates on the markets."

Herzog explains that interest rates on corporate debt will also rise, because of the perceived higher risk, which will lead to price rises and a higher rate of inflation. Inflation, currently running at an annual rate of 3.6%, is not expected to moderate significantly until the second quarter of next year.

Will the banks be harmed?

In the downgrades of Israel’s sovereign ratings this year, some of the rating agencies also downgraded the ratings of Israel’s banks. The reason for that is that the banks are considered entities that the state will support in a crisis, and when the state’s rating falls, then, theoretically, so does its ability to support the banks. Following its previous downgrade of Israel’s rating, Moody’s also downgraded the five major banks in Israel: Leumi, Hapoalim, Mizrahi Tefahot, Discount, and First International.

Harel Gilon, joint CEO of Oppenheimer & Co. Inc. Israel, told "Globes" that he thought that the downgrade would have an immediate effect on the financial markets.

"The banks are in effect a derivative of the state, and we will now see their costs of raising debt rising accordingly," he said, although he hedged that by saying, "Examination of the banks shows that the vast majority of their profits come from the Israeli economy, and so if there is no change in the local economy I see no dramatic change in their profits as a result of the downgrade."

The main indices on the Tel Aviv Stock Exchange have actually risen strongly this morning. The Tel Aviv 35 Index is currently up 1.55%, at 2,128.16 points.

Published by Globes, Israel business news - en.globes.co.il - on September 29, 2024.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2024.

Moody's offices in Vilnius  credit: Shutterstock/Andrius Zemaitis
Moody's offices in Vilnius credit: Shutterstock/Andrius Zemaitis
Commuter jam credit: Eyal Izhar Israeli commuters impose 45 minute limit

Data show that employees would rather change jobs than travel longer, so companies with fast public transport access find it easiest to hire.

Nochi Danner credit: Tamar Matsafi Nochi Dankner reinvented

Still mired in debt, a court case sheds light on the new life of the former 'golden boy' of Israeli business, since his release from prison.

Relocation credit: Michal Raz-Haimovitz How to turn the tech relocation tide

With thousands of tech employees leaving Israel, the Innovation Authority proposes measures that could reverse the trend.

Gal Rosenblum credit: Jonathan Bloom Israel's Adidas franchise chief boosted 2024 sales 40%

Gal Rosenblum talks about his perfect job, which combines his love of sport, fashion and data analysis.

Michael Rogers  credit: Team8 The spy who came into Israeli tech

Former US National Security Agency head Michael Rogers is now a partner at VC fund Team8. He talks to "Globes" about intelligence, geopolitics, and what amazes him about Israel's tech industry.

Dr. Neal Tsur credit: Yossi Zamir "Trump was just an excuse for market drop"

Dr. Neal Tsur studies what makes complex systems like stock markets ripe for change, and he has put his money where his theory is.

Roy Goldenberg  credit: Jonathan Bloom Making a better world for the disabled

Personal experience motivated Roy Goldenberg to become Israel director of TOM Tikkun Olam Makers. "TOM will be one of the biggest organizations to come out of Israel," he says.

Itay Raved  credit: Jonathan Bloom From a rooftop in India to running Tesla Israel

Itay Raved's career drifted from law to media consulting to acting, before he finally found his niche.

Dr. Adi Tzoref-Lorenz credit: Jonathan Bloom "My research says I don't accept there is no answer"

The death of a cancer patient spurred Dr. Adi Zoref-Lorenz into developing the OHI index, which allows the diagnosis of the HLH side effect from cancer immunotherapy, based on two blood tests.

Dr. R  credit: Jonathan Bloom Wounded in his tank, now R develops protection systems

"I was close to death, but it sharpened my awareness of the products we develop for the IDF."

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018